The PIF's Poison Pill WITHIN Lucid ⚠️ When the PIF Would Take Lucid Private │ Important Update
Overall SentimentBearishStrength: 50%
Overall Thesis
PIF's preferred stock structure functions as a poison pill that gives it increasing ownership as dilution accumulates, potentially enabling a low-cost privatization of Lucid by 2026-2027 if the stock continues declining.
Narratives
LCIDLucid Motors
BearishThe 100,000 convertible preferred shares issued by Lucid in March 2024 at a $3.59 conversion price function as a poison pill: as dilution and stock price decline continue, PIF gets proportionally more shares. If Lucid stock keeps falling and gravity underperforms through 2026-2027, PIF could accumulate 70-75% of the float and take the company private for just $1-2B, potentially leaving public shareholders with a modest 40-50% premium over a depressed stock price.
Key Arguments
- 100,000 preferred shares issued March 2024 with $3.59 conversion price — declining as dilution grows
- More dilution = lower conversion price = more PIF shares = path to privatization
- If PIF reaches 70-75% ownership, only $1-2B needed to take Lucid private
- Takeover speculation caused 90% stock spike in January 2023
- Preferred shareholders also accumulate more shares the longer they hold (up to 108 months)
- Previous short interest of 8% in August 2021 despite having only a prototype — suspicious shorting pattern
Analyzed with manual_claude_session | Extraction manual_v1 | Cost: —